Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

PharmaEssentia Corporation (TWO: 6446)

 
6446 Technical Analysis
5
As on 26th Mar 2024 6446 STOCK Price closed @ 318.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 429.80 & Strong Sell for SHORT-TERM with Stoploss of 501.64 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

6446STOCK Price

Open 328.00 Change Price %
High 328.00 1 Day -7.50 -2.30
Low 316.00 1 Week -8.50 -2.60
Close 318.00 1 Month 4.00 1.27
Volume 1354347 1 Year -258.00 -44.79
52 Week High 591.00 | 52 Week Low 283.00
 
TWO Taiwan Most Active Stocks
1815 92.30 1.10%
6173 67.50 6.13%
5340 64.10 9.95%
5498 26.80 3.47%
3260 220.50 -0.45%
5328 21.35 2.64%
8088 48.00 -3.03%
5351 45.65 -4.20%
4979 205.00 4.86%
8936 62.40 -9.96%
 
TWO Taiwan Top Gainers Stocks
8043 58.40 9.98%
8043 58.40 9.98%
5274 6335.00 9.98%
5274 6335.00 9.98%
5340 64.10 9.95%
8042 46.55 9.92%
8042 46.55 9.92%
3537 53.80 9.91%
6265 19.45 9.89%
8444 10.25 9.86%
 
TWO Taiwan Top Losers Stocks
3202 3.96 -10.00%
8936 62.40 -9.96%
2924 23.00 -8.55%
6727 150.00 -7.12%
4549 126.00 -6.32%
3625 22.05 -6.17%
3217 175.00 -5.91%
4130 22.65 -5.62%
4130 22.65 -5.62%
8059 22.10 -5.56%
 
 
6446
Daily Charts		 6446
Intraday Charts		 Whats New @
Bazaartrend		 6446
Free Analysis
 
6446 Important Levels Intraday
RESISTANCE341.12
RESISTANCE333.71
RESISTANCE329.12
RESISTANCE324.54
SUPPORT311.46
SUPPORT306.88
SUPPORT302.29
SUPPORT294.88
 
6446 Forecast November 2025
Share
4th UP Forecast547.31
3rd UP Forecast473.77
2nd UP Forecast428.31
1st UP Forecast382.86
1st DOWN Forecast253.15
2nd DOWN Forecast207.69
3rd DOWN Forecast162.23
4th DOWN Forecast88.69
 
6446 Weekly Forecast
4th UP Forecast551.17
3rd UP Forecast476.39
2nd UP Forecast430.17
1st UP Forecast383.95
1st DOWN Forecast252.06
2nd DOWN Forecast205.83
3rd DOWN Forecast159.61
4th DOWN Forecast84.83
 
6446 Forecast2025
4th UP Forecast942.35
3rd UP Forecast742.12
2nd UP Forecast618.35
1st UP Forecast494.58
1st DOWN Forecast141.42
2nd DOWN Forecast17.65
3rd DOWN Forecast-106.12
4th DOWN Forecast-306.35
 
 
6446 Other Details
Segment EQ
Market Capital 25268811776.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
6446 Address
6446
 
6446 Latest News
 
Your Comments and Response on PharmaEssentia Corporation
 
6446 Business Profile
PharmaEssentia Corporation engages in the research, development, production, and sale of therapeutic products for the treatment of human diseases. Its products include ropeginterferon alfa-2b that is used for the treatment of polycythemia vera, essential thrombocythemia, and hepatitis B and C; and Anti-PD-1 antibody for the treatment of cancer. The company also licensed to develop Oraxol for the treatment of breast, advanced gastric, and esophageal cancer; KX01 for the treatment of psoriasis and actinic keratosis. It also focuses on the drug research and development programs in the areas of hematology, infectious disease, oncology, and dermatology. The company has a research collaboration agreement with Axis Therapeutics Limite for the development of T Cell Receptor-T therapy based on the T cell receptor affinity enhancing specific T cell therapy technology platform. PharmaEssentia Corporation was founded in 2003 and is headquartered in Taipei, Taiwan. Address:
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service